Former U.S. DOJ Deputy Assistant Attorney General Alex Okuliar Joins Morrison & Foerster as Global Antitrust Co-Chair in Washington, D.C.
Share Article
Mr. Okuliar’s arrival underscores the continued expansion of the firm’s global antitrust capabilities and Washington, D.C. office; third senior DOJ official to join the firm since the start of the year WASHINGTON, D.C. (PRWEB) March 16, 2021
Morrison & Foerster, a leading global law firm, is pleased to announce the arrival of Alexander P. Okuliar as a partner in its Antitrust Practice Group in Washington, D.C. Mr. Okuliar will serve as co-chair of the firm’s Global Antitrust Practice Group with current co-chairs Jeff Jaeckel and Lisa Phelan. He brings to the firm over two decades of experience, both in government and private practice roles. Mr. Okuliar joins the firm from the U.S. Department of Justice (DOJ), where he most recently served as Deputy Assistant
Famed Attorney Bobby Lee Cook Dies At 94 - Chattanoogan com
chattanoogan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chattanoogan.com Daily Mail and Mail on Sunday newspapers.
Quarles & Brady Names Tragesser Managing Partner
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
Housing and Development Newsletter
He is an attorney who has worked at organizations dedicated to social justice, digital rights, and free expression. He is a fiction writer, including the award-winning novel, “After the Flare,” and has had work published in Vice, the Washington Post, The Atlantic, and The Guardian.
Olukotun is a graduate of Yale University and Stanford University Law School, and also holds a master s of philosophy from University of Cape Town.
Sprague is an immunologist and passionate advocate for science education. She currently serves as a senior advisory board member of NKMax America, Inc., a clinical stage biotechnology company focused on the development of unique natural killer cell therapies to treat solid tumors.